{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T07:02:53Z","timestamp":1783666973687,"version":"3.55.0"},"reference-count":36,"publisher":"American Society for Microbiology","issue":"8","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Vaccine Immunol"],"published-print":{"date-parts":[[2010,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            The establishment of an aerosol challenge model in nonhuman primates (NHPs) for the testing of vaccines against\n            <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n            would assist the global effort to optimize novel vaccination strategies. The endpoints used in preclinical challenge studies to identify measures of disease burden need to be accurate and sensitive enough to distinguish subtle differences and benefits afforded by different tuberculosis (TB) vaccine regimens when group sizes are inevitably small. This study sought to assess clinical and nonclinical endpoints as potentially sensitive measures of disease burden in a challenge study with rhesus macaques by using a new protocol of aerosol administration of\n            <jats:italic>M. tuberculosis<\/jats:italic>\n            . Immunological and clinical readouts were assessed for utility in vaccine evaluation studies. This is the first example of TB vaccine evaluation with rhesus macaques where long-term survival was one of the primary endpoints. However, we found that in NHP vaccine efficacy studies with maximum group sizes of six animals, survival did not provide a valuable endpoint. Two approaches used in human clinical trials for the evaluation of the gamma interferon (IFN-\u03b3) response to vaccination (enzyme-linked immunospot [ELISpot] assay and enzyme-linked immunosorbent assay [ELISA]) were included in this study. The IFN-\u03b3 profiles induced following vaccination were found not to correlate with protection, nor did the level of purified protein derivative (PPD)-specific proliferation. The only readout to reliably distinguish vaccinated and unvaccinated NHPs was the determination of lung lesion burden using magnetic resonance (MR) imaging combined with stereology at the end of the study. Therefore, the currently proposed key markers were not shown to correlate with protection, and only imaging offered a potentially reliable correlate.\n          <\/jats:p>","DOI":"10.1128\/cvi.00079-10","type":"journal-article","created":{"date-parts":[[2010,6,10]],"date-time":"2010-06-10T01:48:44Z","timestamp":1276134524000},"page":"1170-1182","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":113,"title":["Establishment of an Aerosol Challenge Model of Tuberculosis in Rhesus Macaques and an Evaluation of Endpoints for Vaccine Testing"],"prefix":"10.1128","volume":"17","author":[{"given":"S. A.","family":"Sharpe","sequence":"first","affiliation":[{"name":"Health Protection Agency, Centre for Emergency Preparedness and Response, Porton Down, Salisbury, United Kingdom"},{"name":"the Jenner Institute, University of Oxford, Oxford, United Kingdom"},{"name":"Colorado State University, Fort Collins, Colorado"},{"name":"Churchill Hospital, Headington, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"McShane","sequence":"additional","affiliation":[{"name":"Health Protection Agency, Centre for Emergency Preparedness and Response, Porton Down, Salisbury, United Kingdom"},{"name":"the Jenner Institute, University of Oxford, Oxford, United Kingdom"},{"name":"Colorado State University, Fort Collins, Colorado"},{"name":"Churchill Hospital, Headington, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. J.","family":"Dennis","sequence":"additional","affiliation":[{"name":"Health Protection Agency, Centre for Emergency Preparedness and Response, Porton Down, Salisbury, United Kingdom"},{"name":"the Jenner Institute, University of Oxford, Oxford, United Kingdom"},{"name":"Colorado State University, Fort Collins, Colorado"},{"name":"Churchill Hospital, Headington, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. J.","family":"Basaraba","sequence":"additional","affiliation":[{"name":"Health Protection Agency, Centre for Emergency Preparedness and Response, Porton Down, Salisbury, United Kingdom"},{"name":"the Jenner Institute, University of Oxford, Oxford, United Kingdom"},{"name":"Colorado State University, Fort Collins, Colorado"},{"name":"Churchill Hospital, Headington, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Gleeson","sequence":"additional","affiliation":[{"name":"Health Protection Agency, Centre for Emergency Preparedness and Response, Porton Down, Salisbury, United Kingdom"},{"name":"the Jenner Institute, University of Oxford, Oxford, United Kingdom"},{"name":"Colorado State University, Fort Collins, Colorado"},{"name":"Churchill Hospital, Headington, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Hall","sequence":"additional","affiliation":[{"name":"Health Protection Agency, Centre for Emergency Preparedness and Response, Porton Down, Salisbury, United Kingdom"},{"name":"the Jenner Institute, University of Oxford, Oxford, United Kingdom"},{"name":"Colorado State University, Fort Collins, Colorado"},{"name":"Churchill Hospital, Headington, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"McIntyre","sequence":"additional","affiliation":[{"name":"Health Protection Agency, Centre for Emergency Preparedness and Response, Porton Down, Salisbury, United Kingdom"},{"name":"the Jenner Institute, University of Oxford, Oxford, United Kingdom"},{"name":"Colorado State University, Fort Collins, Colorado"},{"name":"Churchill Hospital, Headington, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Gooch","sequence":"additional","affiliation":[{"name":"Health Protection Agency, Centre for Emergency Preparedness and Response, Porton Down, Salisbury, United Kingdom"},{"name":"the Jenner Institute, University of Oxford, Oxford, United Kingdom"},{"name":"Colorado State University, Fort Collins, Colorado"},{"name":"Churchill Hospital, Headington, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Clark","sequence":"additional","affiliation":[{"name":"Health Protection Agency, Centre for Emergency Preparedness and Response, Porton Down, Salisbury, United Kingdom"},{"name":"the Jenner Institute, University of Oxford, Oxford, United Kingdom"},{"name":"Colorado State University, Fort Collins, Colorado"},{"name":"Churchill Hospital, Headington, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. E. R.","family":"Beveridge","sequence":"additional","affiliation":[{"name":"Health Protection Agency, Centre for Emergency Preparedness and Response, Porton Down, Salisbury, United Kingdom"},{"name":"the Jenner Institute, University of Oxford, Oxford, United Kingdom"},{"name":"Colorado State University, Fort Collins, Colorado"},{"name":"Churchill Hospital, Headington, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Nuth","sequence":"additional","affiliation":[{"name":"Health Protection Agency, Centre for Emergency Preparedness and Response, Porton Down, Salisbury, United Kingdom"},{"name":"the Jenner Institute, University of Oxford, Oxford, United Kingdom"},{"name":"Colorado State University, Fort Collins, Colorado"},{"name":"Churchill Hospital, Headington, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"White","sequence":"additional","affiliation":[{"name":"Health Protection Agency, Centre for Emergency Preparedness and Response, Porton Down, Salisbury, United Kingdom"},{"name":"the Jenner Institute, University of Oxford, Oxford, United Kingdom"},{"name":"Colorado State University, Fort Collins, Colorado"},{"name":"Churchill Hospital, Headington, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Marriott","sequence":"additional","affiliation":[{"name":"Health Protection Agency, Centre for Emergency Preparedness and Response, Porton Down, Salisbury, United Kingdom"},{"name":"the Jenner Institute, University of Oxford, Oxford, United Kingdom"},{"name":"Colorado State University, Fort Collins, Colorado"},{"name":"Churchill Hospital, Headington, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Dowall","sequence":"additional","affiliation":[{"name":"Health Protection Agency, Centre for Emergency Preparedness and Response, Porton Down, Salisbury, United Kingdom"},{"name":"the Jenner Institute, University of Oxford, Oxford, United Kingdom"},{"name":"Colorado State University, Fort Collins, Colorado"},{"name":"Churchill Hospital, Headington, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. V. S.","family":"Hill","sequence":"additional","affiliation":[{"name":"Health Protection Agency, Centre for Emergency Preparedness and Response, Porton Down, Salisbury, United Kingdom"},{"name":"the Jenner Institute, University of Oxford, Oxford, United Kingdom"},{"name":"Colorado State University, Fort Collins, Colorado"},{"name":"Churchill Hospital, Headington, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Williams","sequence":"additional","affiliation":[{"name":"Health Protection Agency, Centre for Emergency Preparedness and Response, Porton Down, Salisbury, United Kingdom"},{"name":"the Jenner Institute, University of Oxford, Oxford, United Kingdom"},{"name":"Colorado State University, Fort Collins, Colorado"},{"name":"Churchill Hospital, Headington, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. D.","family":"Marsh","sequence":"additional","affiliation":[{"name":"Health Protection Agency, Centre for Emergency Preparedness and Response, Porton Down, Salisbury, United Kingdom"},{"name":"the Jenner Institute, University of Oxford, Oxford, United Kingdom"},{"name":"Colorado State University, Fort Collins, Colorado"},{"name":"Churchill Hospital, Headington, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","first-page":"363","volume":"143","year":"1972","unstructured":"Anacker, R. L., W. Brehmer, W. R. Barclay, W. R. Leif, E. Ribi, J. H. Simmons, and A. W. Smith. 1972. Superiority of intravenously administered BCG and BCG cell walls in protecting rhesus monkeys (Macaca mulatta) against airborne tuberculosis. Z. Immunitatsforsch. Exp. Klin. Immunol.143:363-376.","journal-title":"Z. Immunitatsforsch. Exp. Klin. Immunol."},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.2.5.574-582.1970"},{"key":"e_1_3_2_4_2","first-page":"351","volume":"107","year":"1973","unstructured":"Barclay, W. R., W. M. Busey, D. W. Dalgard, R. C. Good, B. W. Janicki, J. E. Kasik, E. Ribi, C. E. Ulrich, and E. Wolinsky. 1973. Protection of monkeys against airborne tuberculosis by aerosol vaccination with bacillus Calmette-Guerin. Am. Rev. Respir. Dis.107:351-358.","journal-title":"Am. Rev. Respir. Dis."},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/S1472-9792(08)70035-0","volume":"88","year":"2008","unstructured":"Basaraba, R. J. 2008. Experimental tuberculosis: the role of comparative pathology in the discovery of improved tuberculosis treatment strategies. Tuberculosis (Edinb.)88(Suppl. 1):S35-S47.","journal-title":"Tuberculosis (Edinb.)"},{"key":"e_1_3_2_6_2","first-page":"664","volume":"5","year":"2001","unstructured":"Black, G. F., P. E. M. Fine, D. K. Warndorff, S. Floyd, R. E. Weir, J. M. Blackwell, L. Bliss, L. Sichali, L. Mwaungulu, S. Chaguluka, E. Jarman, B. Ngwira, and H. M. Dockrell. 2001. Relationship between IFN-gamma and skin test responsiveness to Mycobacterium tuberculosis PPD in healthy, non-BCG-vaccinated young adults in Northern Malawi. Int. J. Tuber. Lung Dis.5:664-672.","journal-title":"Int. J. Tuber. Lung Dis."},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200737504"},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1099\/0022-1317-79-5-1159","volume":"79","year":"1998","unstructured":"Blanchard, T. J., A. Alcami, P. Andrea, and G. L. Smith. 1998. Modified vaccinia virus Ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins: implications for use as a human vaccine. J. Gen. Virol.79:1159-1167.","journal-title":"J. Gen. Virol."},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.71.10.5831-5844.2003"},{"key":"e_1_3_2_10_2","first-page":"43","volume":"112","year":"1975","unstructured":"Chaparas, S. D., R. C. Good, and B. W. Janicki. 1975. Tuberculin-induced lymphocyte transformation and skin reactivity in monkeys vaccinated or not vaccinated with bacille Calmette-Guerin, then challenged with virulent Mycobacterium tuberculosis. Am. Rev. Respir. Dis.112:43-47.","journal-title":"Am. Rev. Respir. Dis."},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","volume":"271","year":"1994","unstructured":"Colditz, G. A., T. F. Brewer, C. S. Berkey, M. E. Wilson, E. Burdick, H. V. Fineberg, and F. Mosteller. 1994. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA271:698-702.","journal-title":"JAMA"},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1017\/S0022172400041851","volume":"67","year":"1969","unstructured":"Druett, H. A. 1969. A mobile form of the Henderson apparatus. J. Hyg. (Lond.)67:437-448.","journal-title":"J. Hyg. (Lond.)"},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1749-6632.1968.tb16710.x","volume":"154","year":"1968","unstructured":"Good, R. C. 1968. Simian tuberculosis: immunologic aspects. Ann. N. Y. Acad. Sci.154:200-213.","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.4049\/jimmunol.171.3.1602","volume":"171","year":"2003","unstructured":"Goonetilleke, N. P., H. McShane, C. M. Hannan, R. J. Anderson, R. H. Brookes, and A. V. Hill. 2003. Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Gu\u00e9rin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara. J. Immunol.171:1602-1609.","journal-title":"J. Immunol."},{"key":"e_1_3_2_15_2","first-page":"359","volume":"107","year":"1973","unstructured":"Janicki, B. W., R. C. Good, P. Minden, L. F. Affronti, and W. F. Hymes. 1973. Immune responses in rhesus monkeys after bacille Calmette-Guerin vaccination and aerosol challenge with Mycobacterium tuberculosis. Am. Rev. Respir. Dis.107:359-366.","journal-title":"Am. Rev. Respir. Dis."},{"key":"e_1_3_2_16_2","first-page":"11497","volume":"98","year":"2000","unstructured":"Langermans, J. A. M., P. Anderson, D. van Soolingen, R. A. W. Verenne, P. A. Frost, T. van der Laan, S. Kroon, I. Peekel, S. Florquin, and A. W. Thomas. 2000. Divergent effect of bacillus Calmette-Guerin (BCG) vaccination on Mycobacterium tuberculosis infection in highly related macaque species: implications for primate models in tuberculosis vaccine research. Proc. Natl. Acad. Sci. U. S. A.98:11497-11502.","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00064-06"},{"key":"e_1_3_2_18_2","first-page":"157","volume":"215","year":"1996","unstructured":"McMurray, D. N., F. M. Collins, A. M. Dannenberg, Jr., and D. W. Smith. 1996. Pathogenesis of experimental tuberculosis in animal models. Curr. Top. Microbiol. Immunol.215:157-179.","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"S210","DOI":"10.1086\/313885","volume":"30","year":"2000","unstructured":"McMurray, D. N. 2000. A non-human primate model for the preclinical testing of new tuberculosis vaccines. Clin. Infect. Dis.30(Suppl. 3):S210-S212.","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.2.681-686.2001"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1128"},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"e1052","DOI":"10.1371\/journal.pone.0001052","volume":"2","year":"2007","unstructured":"Pathan, A. A., C. R. Sander, H. A. Fletcher, I. Poulton, N. C. Alder, A. V. Hill, and H. McShane. 2007. Safety and immunogenicity of boosting BCG vaccinated subjects with BCG: comparison with boosting with a new TB vaccine, MVA85A. PLoS One2:e1052.","journal-title":"PLoS One"},{"key":"e_1_3_2_23_2","first-page":"3267","volume":"26","year":"2009","unstructured":"Okada, M., Y. Kita, T. Nakajima, N. Kanamaru, S. Hashimoto, T. Nagasawa, Y. Kaneda, S. Yoshida, Y. Nishida, H. Nakatani, K. Takao, C. Kishigami, Y. Inoue, M. Matsumoto, D. N. McMurray, E. C. Dela Cruz, E. V. Tan, R. M. Abalos, J. A. Burgos, P. Saunderson, and M. Sakatani. 2009. Novel prophylactic and therapeutic vaccine against tuberculosis. Vaccine26:3267-3270. [Epub ahead of print.]","journal-title":"Vaccine"},{"key":"e_1_3_2_24_2","first-page":"2990","volume":"20","year":"2007","unstructured":"Okada, M., Y. Kita, T. Nakajima, N. Kanamaru, S. Hashimoto, T. Nagasawa, Y. Kaneda, S. Yoshida, Y. Nishida, R. Fukamizu, Y. Tsunai, R. Inoue, H. Nakatani, Y. Namie, J. Yamada, K. Takao, R. Asai, R. Asaki, M. Matsumoto, D. N. McMurray, E. C. Dela Cruz, E. V. Tan, R. M. Abalos, J. A. Burgos, R. Gelber, and M. Sakatani. 2007. Evaluation of a novel vaccine (HVJ-liposome\/HSP65 DNA+IL-12 DNA) against tuberculosis using the cynomolgus monkey model of TB. Vaccine20:2990-2993.","journal-title":"Vaccine"},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0966-842X(00)01949-1","volume":"9","year":"2001","unstructured":"Orme, I. M., D. N. McMurray, and J. T. Belisle. 2001. Tuberculosis vaccine development: recent progress. Trends Microbiol.9:115-118.","journal-title":"Trends Microbiol."},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0712077106"},{"key":"e_1_3_2_27_2","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/infdis\/123.5.527","volume":"123","year":"1971","unstructured":"Ribi, E., R. L. Anacker, W. R. Barclay, W. Brehmer, S. C. Harris, W. R. Leif, and J. Simmons. 1971. Efficacy of mycobacterial cell walls as a vaccine against airborne tuberculosis in the rhesus monkey. J. Infect. Dis.123:527-538.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/ije\/22.6.1154","volume":"22","year":"1993","unstructured":"Rodrigues, L. C., V. K. Diwan, and J. G. Wheeler. 1993. Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis. Int. J. Epidemiol.22:1154-1158.","journal-title":"Int. J. Epidemiol."},{"key":"e_1_3_2_29_2","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.tube.2009.09.002","volume":"89","year":"2009","unstructured":"Sharpe, S. A., E. Eschelbach, R. J. Basaraba, F. Gleeson, G. A. Hall, A. McIntyre, A. Williams, S. L. Kraft, S. Clark, K. Gooch, G. Hatch, I. M. Orme, P. D. Marsh, and M. J. Dennis. 2009. Determination of lesion volume by MRI and stereology in a macaque model of tuberculosis. Tuberculosis89:405-416. [Epub ahead of print.]","journal-title":"Tuberculosis"},{"key":"e_1_3_2_30_2","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1126\/science.1068819","volume":"295","year":"2002","unstructured":"Shen, Y., D. Zhou, L. Qiu, X. Lai, M. Simon, L. Shen, Z. Kou, Q. Wang, L. Jiang, J. Estep, R. Hunt, M. Clagett, P. K. Sehgal, Y. Li, X. Zeng, C. T. Morita, M. B. Brenner, N. L. Letvin, and Z. W. Chen. 2002. Adaptive immune responses of V\u03b32V\u03b42+ T cells during mycobacterial infections. Science295:2255-2258.","journal-title":"Science"},{"key":"e_1_3_2_31_2","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(06)68507-3","volume":"367","year":"2006","unstructured":"Trunz, B. B., P. Fine, and C. Dye. 2006. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet367:1173-1180.","journal-title":"Lancet"},{"key":"e_1_3_2_32_2","doi-asserted-by":"crossref","first-page":"e5264","DOI":"10.1371\/journal.pone.0005264","volume":"4","year":"2009","unstructured":"Verreck, F. A. W., R. A. W. Vervenne, I. Kondova, K. W. van Kralingen, E. J. Remarque, G. Braskamp, N. M. van der Werff, A. Kersbergen, T. H. M. Ottenhoff, P. J. Heidt, S. C. Gilbert, B. Gicquel, A. V. S. Hill, C. Martin, H. McShane, and A. W. Thomas. 2009. MVA.85A boosting of BCG and an attenuated phoP deficient M. tuberculosis vaccine both show protective efficacy against tuberculosis in rhesus macaques. PLoS One4:e5264.","journal-title":"PLoS One"},{"key":"e_1_3_2_33_2","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-2567.2004.01903.x","volume":"112","year":"2004","unstructured":"Vordermeier, H. M., S. G. Rhodes, G. Dean, N. Goonetilleke, K. Huygen, A. V. Hill, R. G. Hewinson, and S. C. Gilbert. 2004. Cellular immune responses induced in cattle by heterologous prime-boost vaccination using recombinant viruses and bacille Calmette-Gu\u00e9rin. Immunology112:461-470.","journal-title":"Immunology"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00287-09"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.73.6.3814-3816.2005"},{"key":"e_1_3_2_36_2","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.tube.2009.08.004","volume":"89","year":"2009","unstructured":"Williams, A., Y. Hall, and I. M. Orme. 2009. Evaluation of new vaccines for tuberculosis in the guinea pig model. Tuberculosis (Edinb.)89:389-397. [Epub ahead of print.]","journal-title":"Tuberculosis (Edinb.)"},{"key":"e_1_3_2_37_2","unstructured":"Global tuberculosis control: surveillance planning financing 2008"}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00079-10","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00079-10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T20:43:44Z","timestamp":1627591424000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.00079-10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["10.1128\/CVI.00079-10"],"URL":"https:\/\/doi.org\/10.1128\/cvi.00079-10","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8]]},"assertion":[{"value":"2010-03-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2010-06-01","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}